- Home
- VFS vs MRNA Comparison
VFS vs MRNA Comparison
Compare VFS & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- MRNA
- Stock Information
- Founded
- VFS 2017
- MRNA 2010
- Country
- VFS Vietnam
- MRNA United States
- Employees
- VFS N/A
- MRNA N/A
- Industry
- VFS Blank Checks
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VFS Finance
- MRNA Health Care
- Exchange
- VFS Nasdaq
- MRNA Nasdaq
- Market Cap
- VFS 8.0B
- MRNA 9.2B
- IPO Year
- VFS N/A
- MRNA 2018
- Fundamental
- Price
- VFS $3.42
- MRNA $27.08
- Analyst Decision
- VFS Buy
- MRNA Hold
- Analyst Count
- VFS 3
- MRNA 15
- Target Price
- VFS $5.75
- MRNA $36.69
- AVG Volume (30 Days)
- VFS 587.6K
- MRNA 12.1M
- Earning Date
- VFS 11-21-2025
- MRNA 11-06-2025
- Dividend Yield
- VFS N/A
- MRNA N/A
- EPS Growth
- VFS N/A
- MRNA N/A
- EPS
- VFS N/A
- MRNA N/A
- Revenue
- VFS $2,363,353,531.00
- MRNA $2,232,000,000.00
- Revenue This Year
- VFS $93.28
- MRNA N/A
- Revenue Next Year
- VFS $39.53
- MRNA $10.38
- P/E Ratio
- VFS N/A
- MRNA N/A
- Revenue Growth
- VFS 86.03
- MRNA N/A
- 52 Week Low
- VFS $2.56
- MRNA $23.04
- 52 Week High
- VFS $5.38
- MRNA $48.92
- Technical
- Relative Strength Index (RSI)
- VFS 55.74
- MRNA 55.06
- Support Level
- VFS $3.10
- MRNA $23.04
- Resistance Level
- VFS $3.63
- MRNA $25.56
- Average True Range (ATR)
- VFS 0.13
- MRNA 1.58
- MACD
- VFS 0.03
- MRNA 0.07
- Stochastic Oscillator
- VFS 61.32
- MRNA 65.26
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.